|
/01. Antimicrobial Pharmacology/
|
|
01.01 Overview – Cell Wall Synthesis Inhibitors (Antibiotics).mp4
|
7.2 MB
|
|
01.02 Penicillins – Cell Wall Synthesis Inhibitors (Antibiotics).mp4
|
31.6 MB
|
|
01.03 Cephalosporins – Cell Wall Synthesis Inhibitors (Antibiotics).mp4
|
21.1 MB
|
|
01.04 Carbapenems – Cell Wall Synthesis Inhibitors (Antibiotics).mp4
|
7.3 MB
|
|
01.05 Vancomycin, Bacitracin and Daptomycin – Cell Wall Synthesis Inhibitors (Antibiotics).mp4
|
20.6 MB
|
|
01.06 Overview – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp4
|
35.1 MB
|
|
01.07 Linezolid, Streptogramins and Chloramphenicol – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp4
|
32.2 MB
|
|
01.08 Macrolides and Ketolides – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp4
|
25.6 MB
|
|
01.09 Tetracyclines – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp4
|
24.4 MB
|
|
01.10 Aminoglycosides – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp4
|
38.7 MB
|
|
01.11 Quiz Questions and Case Studies – Antibacterial Agents (Antibiotics).mp4
|
50.2 MB
|
|
02.01 Overview – Antimetabolites.mp4
|
5.8 MB
|
|
02.02 Sulfonamides, Trimethoprim and Fluoroquinolones – Antimetabolites.mp4
|
59.5 MB
|
|
02.03 Case Studies – Antimetabolites.mp4
|
23.2 MB
|
|
02.04 Overview – Antimycobacterial Agents.mp4
|
6.8 MB
|
|
02.05 Antituberculosis Drugs – Antimycobacterial Agents.mp4
|
43.7 MB
|
|
02.06 Treatment Regimens for Mycobacterium Tuberculosis, Leprosy and Other Infections – Antimycobacterial Agents.mp4
|
26.1 MB
|
|
02.07 Case Studies – Antimycobacterial Agents.mp4
|
40.8 MB
|
|
03.01 Overview – Antifungals.mp4
|
5.1 MB
|
|
03.02 Azoles – Antifungals.mp4
|
31.8 MB
|
|
03.03 Polyenes – Antifungals.mp4
|
32.5 MB
|
|
03.04 Flucytosine (5-Fluorocytosine5-FU) – Antifungals.mp4
|
10.5 MB
|
|
03.05 Echinocandins and Squalene Epoxidase Inhibitor (Terbinafine) – Antifungals.mp4
|
14.1 MB
|
|
03.06 Questions – Antifungals.mp4
|
19.8 MB
|
|
04.01 Overview – Antiviral Drugs.mp4
|
17.8 MB
|
|
04.02 Anti-HIV Agents Fusion Inhibitors – Antiviral Drugs.mp4
|
10.1 MB
|
|
04.03 Anti-HIV Agents Nucleoside Reverse Transcriptase Inhibitors (NRTI) – Antiviral Drugs.mp4
|
60.1 MB
|
|
04.04 Anti-HIV Agents Reverse Transcriptase Inhibitors (NNRTI) – Antiviral Drugs.mp4
|
33.1 MB
|
|
04.05 Anti-HIV Agents Integrase Strand Transfer Inhibitors – Antiviral Drugs.mp4
|
15.9 MB
|
|
04.06 Anti-HIV Agents Protease Inhibitors – Antiviral Drugs.mp4
|
51.4 MB
|
|
04.07 Anti-HIV Agents CCR5 Antagonist – Antiviral Drugs.mp4
|
15.2 MB
|
|
04.08 Questions about Anti-HIV Agents – Antiviral Drugs.mp4
|
14.5 MB
|
|
04.09 Case Studies about Anti-HIV Agents – Antiviral Drugs.mp4
|
16.6 MB
|
|
04.10 Anti-Herpes Agents Thymidine Kinase Agents – Antiviral Drugs.mp4
|
36.7 MB
|
|
04.11 Anti-Herpes Agents RNA Polymerase Inhibitors and Other Drugs – Antiviral Drugs.mp4
|
24.2 MB
|
|
04.12 Influenza Treatment – Antiviral Drugs.mp4
|
16.1 MB
|
|
04.13 Hepatitis Treatment – Antiviral Drugs.mp4
|
46.1 MB
|
|
04.14 Overview – Antiviral Agents and Treatment of CMV Retinitis – Antiviral Drugs.mp4
|
12.5 MB
|
|
04.15 Case Study – Antiviral Drugs.mp4
|
43.6 MB
|
|
05.01 Antimalarial Drugs – Antiprotozoal Agents.mp4
|
93.0 MB
|
|
05.02 Amebicides – Antiprotozoal Agents.mp4
|
61.0 MB
|
|
05.03 Nematicides – Antihelmintic Drugs.mp4
|
38.3 MB
|
|
05.04 Trematocides (Praziquantel) and Cestodicides (Niclosamide) – Antihelmintic Drugs.mp4
|
16.2 MB
|
|
05.05 Questions – Antiprotozoal and Antihelmintic Drugs.mp4
|
21.6 MB
|
|
/02. Pharmacokinetics and Pharmacodynamics/
|
|
01.01 Introduction to Kinetics Pharmacokinetics (PK).mp4
|
33.6 MB
|
|
01.02 Hydrophilic vs. Hydrophobic – Absorption and Distribution Pharmacokinetics (PK).mp4
|
28.3 MB
|
|
01.03 pKa and Drug Solubility – Absorption and Distribution Pharmacokinetics (PK).mp4
|
38.3 MB
|
|
01.04 Drug Distribution – Absorption and Distribution Pharmacokinetics (PK).mp4
|
38.3 MB
|
|
01.05 Phases of Drug Development – Absorption and Distribution Pharmacokinetics (PK).mp4
|
40.5 MB
|
|
02.01 Drug Metabolism – Biotransformation Pharmacokinetics (PK).mp4
|
51.8 MB
|
|
02.02 Factors Affecting Drug Metabolism – Biotransformation Pharmacokinetics (PK).mp4
|
113.3 MB
|
|
03.01 Introduction and Definitions of Pharmacodynamics – Pharmacodynamics.mp4
|
16.9 MB
|
|
03.02 Drug Receptors and Effectors – Pharmacodynamics.mp4
|
17.8 MB
|
|
03.03 Upregulation and Downregulation – Pharmacodynamics.mp4
|
5.6 MB
|
|
03.04 Dose-Response, Binding, Quantal, Toxicity & Potency Curves – Pharmacodynamics.mp4
|
76.0 MB
|
|
04.01 Introduction esp. Types of Eliminations – Elimination Kinetics.mp4
|
23.6 MB
|
|
04.02 First Pass Metabolism – Elimination Kinetics.mp4
|
14.1 MB
|
|
04.03 Bioavailability incl. Case Study – Elimination Kinetics.mp4
|
15.8 MB
|
|
04.04 Dosage Calculation Maintenance Dose and Loading Dose – Elimination Kinetics.mp4
|
37.4 MB
|
|
04.05 Intravenous vs. Oral Medications – Elimination Kinetics.mp4
|
9.1 MB
|
|
04.06 Renal Clearance – Elimination Kinetics.mp4
|
34.3 MB
|
|
/03. Inflammation Pharmacology/
|
|
01. Pharmacology of Inflammation.mp4
|
50.3 MB
|
|
02. Acetylsalicylic Acid (ASA).mp4
|
32.9 MB
|
|
03. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).mp4
|
21.6 MB
|
|
04. COX-2 Inhibitors.mp4
|
16.5 MB
|
|
05. Disease Modifying Anti Rheumatic Agents (DMARDS).mp4
|
47.2 MB
|
|
06. Gout Medication Colchicine, Uric Acid and More.mp4
|
44.6 MB
|
|
07. Inflammation Pharmacology Questions.mp4
|
28.6 MB
|
|
/04. Endocrine Pharmacology/
|
|
01.01 Insulin – Diabetes Medications.mp4
|
20.0 MB
|
|
01.02 Insulin Types & Glycemic Excursions – Diabetes Medications.mp4
|
26.3 MB
|
|
01.03 Secretagogues and Biguanides – Diabetes Medications.mp4
|
29.3 MB
|
|
01.04 Metformin, Alpha Glucosidase Inhibitors and Thiazolidinediones – Diabetes Medications.mp4
|
42.0 MB
|
|
01.05 DPP-4 Inhibitors and GLP-1 Analogues – Diabetes Medications.mp4
|
29.4 MB
|
|
01.06 SGLT2 Inhibitors – Diabetes Medications.mp4
|
52.6 MB
|
|
01.07 Questions – Diabetes Medications.mp4
|
62.8 MB
|
|
02.01 Overview – Adrenal Pharmacology.mp4
|
4.4 MB
|
|
02.02 Mineralocorticoids and Glucocorticoids – Adrenal Pharmacology.mp4
|
52.2 MB
|
|
02.03 Catecholamines – Adrenal Pharmacology.mp4
|
20.1 MB
|
|
02.04 Questions and Case Studies – Adrenal Pharmacology.mp4
|
23.7 MB
|
|
/05. CNS - Pharmacology/
|
|
01.01 Overview of Sedative and Hypnotic Drugs – Sedative Hypnotics.mp4
|
54.1 MB
|
|
01.02 Benzodiazepines – Sedative Hypnotics.mp4
|
35.0 MB
|
|
01.03 Barbiturates – Sedative Hypnotics.mp4
|
13.4 MB
|
|
01.04 Atypical Antipsychotic Drugs – Sedative Hypnotics.mp4
|
57.0 MB
|
|
01.05 Questions – Sedative Hypnotics.mp4
|
16.3 MB
|
|
01.06 Case Study – Sedative Hypnotics.mp4
|
22.4 MB
|
|
02.01 Overview – Antidepressants.mp4
|
15.2 MB
|
|
02.02 Monoamine Oxidase Inhibitors (MAOIs) – Antidepressants.mp4
|
24.7 MB
|
|
02.03 Tricyclic Antidepressants (TCAs) – Antidepressants.mp4
|
24.2 MB
|
|
02.04 Heterocyclic Antidepressants – Antidepressants.mp4
|
15.0 MB
|
|
02.05 SNRIs, Serotonin Antagonists and SSRIs – Antidepressants.mp4
|
55.1 MB
|
|
02.06 Review – Antidepressants.mp4
|
7.6 MB
|
|
02.07 Questions – Antidepressants.mp4
|
23.9 MB
|
|
03.01 Overview – Antipsychotics.mp4
|
9.5 MB
|
|
03.02 Effects of Increasing Dopamine – Antipsychotics.mp4
|
14.7 MB
|
|
03.03 Bipolar Disorder Medication – Antipsychotics.mp4
|
32.8 MB
|
|
03.04 Psychotic Disorder Medication – Antipsychotics.mp4
|
22.2 MB
|
|
03.05 Clinical Uses of Antipsychotics and Drug Induced Dyskinesia.mp4
|
25.9 MB
|
|
03.06 Questions – Antipsychotics.mp4
|
16.7 MB
|
|
04.01 Dopamine Hypothesis – Medication of Movement Disorders.mp4
|
20.8 MB
|
|
04.02 Dopamine Precursors and Agonists – Treatment of Movement Disorders.mp4
|
48.8 MB
|
|
04.03 MAO and COMT Inhibitors – Treatment of Movement Disorders.mp4
|
23.1 MB
|
|
04.04 Amantadine and Anticholinergics – Medication of Movement Disorders.mp4
|
17.3 MB
|
|
04.05 Postural Tremor, Huntington's Disease, Tourette's Syndrome, Wilsons's Disease and Drug Induced Dyskinesia – Medication of Movement Dis.mp4
|
36.7 MB
|
|
05.01 Overview – Anti-Seizure Medications.mp4
|
26.6 MB
|
|
05.02 Treatment Strategies – Anti-Seizure Medications.mp4
|
68.7 MB
|
|
05.03 Questions – Anti-Seizure Medications.mp4
|
23.1 MB
|
|
06.01 Overview – Anesthetic Drugs.mp4
|
5.2 MB
|
|
06.02 Inhaled Anesthetics – Anesthetic Drugs.mp4
|
31.9 MB
|
|
06.03 General Anesthetics – Anesthetic Drugs.mp4
|
43.6 MB
|
|
06.04 Intravenous Anesthetics – Anesthetic Drugs.mp4
|
25.6 MB
|
|
06.05 Case Study – Anesthetic Drugs.mp4
|
22.8 MB
|
|
07.01 Overview – Skeletal Muscle Relaxants.mp4
|
9.1 MB
|
|
07.02 Neuromuscular Blockers – Skeletal Muscle Relaxants.mp4
|
36.2 MB
|
|
07.03 Acute and Chronic Muscle Spasms – Skeletal Muscle Relaxants.mp4
|
34.8 MB
|
|
07.04 Questions – Skeletal Muscle Relaxants.mp4
|
36.3 MB
|
|
08.01 Overview – Local Anesthetics.mp4
|
41.7 MB
|
|
08.02 Esters and Amides – Local Anesthetics.mp4
|
34.5 MB
|
|
08.03 Overview – Opioid Analgesics.mp4
|
15.8 MB
|
|
08.04 Opioid Agonists – Opioid Analgesics.mp4
|
34.5 MB
|
|
08.05 Mixed AgonistsAntagonists and Antagonists – Opioid Analgesics.mp4
|
33.0 MB
|
|
08.06 Questions – Local Anesthetics and Opioid Analgesics.mp4
|
34.4 MB
|
|
/06. ANS - Pharmacology/
|
|
01.01 Autonomic Nervous System (ANS) Overview.mp4
|
39.8 MB
|
|
01.02 Dual Innervation.mp4
|
24.3 MB
|
|
01.03 Alpha- and Beta-Blockers.mp4
|
31.6 MB
|
|
01.04 Sympathetic Blockers.mp4
|
30.1 MB
|
|
02.01 Cholinomimetic Activators.mp4
|
20.2 MB
|
|
02.02 Cholinomimetic Effects.mp4
|
39.3 MB
|
|
02.03 Special Topic Cholinergic Toxicity, Poisoning, Myestenia Crisis and Cholinergic Crisis.mp4
|
38.7 MB
|
|
03.01 Sympathomimetic Activators.mp4
|
31.8 MB
|
|
03.02 Sympathomimetic Effects.mp4
|
82.9 MB
|
|
03.03 Global Effect of Sympathomimetic Drugs on the Vascular System.mp4
|
38.9 MB
|
|
03.04 Anticholinergic Drugs.mp4
|
59.9 MB
|
|
/07. Respiratory Pharmacology/
|
|
01. Asthma Medications.mp4
|
15.0 MB
|
|
02. Bronchodilators.mp4
|
22.6 MB
|
|
03. Corticosteroids.mp4
|
15.1 MB
|
|
04. Leukotriene Receptor Antagonists.mp4
|
11.9 MB
|
|
05. Anti-Inflammatory Agents Release Inhibitors and IgE-Antibodies.mp4
|
13.6 MB
|
|
06. Asthma Medication Questions.mp4
|
17.0 MB
|
|
/08. Pharmacology of Blood Coagulation/
|
|
01. Overview Coagulant Drugs.mp4
|
6.0 MB
|
|
02. Antiplatelets.mp4
|
46.6 MB
|
|
03. Anticoagulants.mp4
|
72.4 MB
|
|
04. Thrombolytics and Procoagulants.mp4
|
40.9 MB
|
|
05. Questions Coagulant Drugs.mp4
|
22.6 MB
|
|
/09. Gastrointestinal Pharmacology/
|
|
01. Questions and Case Studies Steroids, Cyclosprine and Crohn's Disease.mp4
|
48.0 MB
|
|
02 Inflammatory Bowel Disease Medication.mp4
|
80.3 MB
|
|
03. Stomach Ulcer (Peptic Acid Disease) Medication.mp4
|
53.7 MB
|
|
04. Motility Disorder Medication.mp4
|
56.6 MB
|
|
05. Nausea Medication Antiemetics – Gastrointestinal Drugs.mp4
|
42.6 MB
|
|
06. Pancreatic Enzyme Replacement Therapy (PERT) and Gallstone Prevention – Gastrointestinal Drugs.mp4
|
17.7 MB
|
|
07. Irritable Bowel Syndrome (IBS) Medication.mp4
|
17.7 MB
|
|
08. Questions and Case Studies H2 Blockers, GERD Medication and Domperidone.mp4
|
19.8 MB
|
|
/10. Toxicology/
|
|
03.05 Toxicology Questions & Case Studies.mp4
|
57.9 MB
|
|
Slides 01.pdf
|
2.1 MB
|
|
Slides 02.pdf
|
1.4 MB
|
|
Slides 03.pdf
|
435.7 KB
|
|
/11. Cardiovascular Pharmacology/
|
|
01.01 Introduction to High Blood Pressure Medication – Drugs in Hypertension.mp4
|
10.2 MB
|
|
01.02 Diuretics – Drugs in Hypertension.mp4
|
59.2 MB
|
|
01.03 Renin Angiotensin Aldosterone – Drugs in Hypertension.mp4
|
61.4 MB
|
|
01.04 Vasodilators – Drugs in Hypertension.mp4
|
50.4 MB
|
|
01.05 Alpha Blockers – Drugs in Hypertension.mp4
|
12.3 MB
|
|
01.06 Beta Blockers – Drugs in Hypertension.mp4
|
30.6 MB
|
|
01.07 Postganglionic Sympathetic Nerve Terminal Blockers and Monoamine Oxidase Inhibitors – Drugs in Hypertension.mp4
|
14.0 MB
|
|
01.08 Lines of Therapy – Drugs in Hypertension.mp4
|
49.9 MB
|
|
01.09 Pulmonary Hypertension Medication – Drugs in Hypertension.mp4
|
17.3 MB
|
|
01.10 Questions and Case Studies – Drugs in Hypertension.mp4
|
35.4 MB
|
|
02.01 Introduction – Angina and Heart Failure Management.mp4
|
16.4 MB
|
|
02.02 Nitrates – Angina and Heart Failure Management.mp4
|
29.7 MB
|
|
02.03 Cardiac Depressants, Metabolic Modifiers and Slow Sodium Channel Inhibitors – Angina and Heart Failure Management.mp4
|
22.1 MB
|
|
02.04 Inotropes – Angina and Heart Failure Management.mp4
|
39.1 MB
|
|
02.05 Vasodilators – Angina and Heart Failure Management.mp4
|
18.9 MB
|
|
02.06 Renin-Angiotensin Agents and Beta Blockers – Angina and Heart Failure Management.mp4
|
15.9 MB
|
|
02.07 Questions – Angina and Heart Failure Management.mp4
|
41.1 MB
|
|
03.01 Introduction – Antiarrhythmic Drugs.mp4
|
4.7 MB
|
|
03.02 Group 1 Sodium Channel Blockers – Antiarrhythmic Drugs.mp4
|
34.3 MB
|
|
03.03 Group 2 Beta Blockers – Antiarrhythmic Drugs.mp4
|
12.4 MB
|
|
03.04 Group 3 Potassium Channel Blockers – Antiarrhythmic Drugs.mp4
|
25.1 MB
|
|
03.05 Group 4 Calcium Channel Blockers – Antiarrhythmic Drugs.mp4
|
12.6 MB
|
|
03.06 Group 5 Other Antiarrhythmics – Antiarrhythmic Drugs.mp4
|
26.1 MB
|
|
03.07 Questions – Antiarrhythmic Drugs.mp4
|
22.5 MB
|
|
04.01 Introduction Bile Acid Sequestrants, Niacin and Fibrates – Lipid Control.mp4
|
42.7 MB
|
|
04.02 HMG-CoA Reductase Inhibitors – Lipid Control.mp4
|
66.5 MB
|
|
04.03 Fat Absorption and MTP Inhibitors – Lipid Control.mp4
|
25.5 MB
|
|
04.04 PCSK9 Inhibitors – Lipid Control.mp4
|
58.3 MB
|
|
04.05 Questions – Lipid Control.mp4
|
19.9 MB
|
|
/12. Reproductive Pharmacology/
|
|
01. Overview – Reproductive Pharmacology.mp4
|
10.8 MB
|
|
02. Estrogens and Progestins – Reproductive Pharmacology.mp4
|
69.8 MB
|
|
03. Anti-Estrogens and Antiprogestins – Reproductive Pharmacology.mp4
|
43.7 MB
|
|
04. Androgens and Antiandrogens.mp4
|
42.6 MB
|
|
05. Questions and Case Studies – Reproductive Pharmacology.mp4
|
21.8 MB
|
|
Total files 189
|
